Potts Chicken Stock in 100% Recyclable Can 500ml | Pack of 2

Product Information

Zhang Q, Chen X, Li J, Du J (December 2014). "Clinical features of hyperadrenergic postural tachycardia syndrome in children". Pediatrics International. 56 (6): 813–816. doi: 10.1111/ped.12392. PMID 24862636. S2CID 20740649. Fu Q, Vangundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD (August 2011). "Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome". Hypertension. 58 (2): 167–175. doi: 10.1161/HYPERTENSIONAHA.111.172262. PMC 3142863. PMID 21690484. Cui YX, DU JB, Zhang QY, Liao Y, Liu P, Wang YL, Qi JG, Yan H, Xu WR, Liu XQ, Sun Y, Sun CF, Zhang CY, Chen YH, Jin HF (October 2022). "[A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children]". Beijing Da Xue Xue Bao Yi Xue Ban (in Chinese). 54 (5): 954–960. doi: 10.19723/j.issn.1671-167X.2022.05.024. PMC 9568388. PMID 36241239. Stewart JM (May 2002). "Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects". Circulation. 105 (19): 2274–2281. doi: 10.1161/01.CIR.0000016348.55378.C4. PMID 12010910. S2CID 11618433.

Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, etal. (November 2021). "Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1". Autonomic Neuroscience. 235: 102828. doi: 10.1016/j.autneu.2021.102828. PMC 8455420. PMID 34144933. Aggravating factors include exertion (81%), continued standing (80%), heat (79%), and after meals (42%). [84] Medication [ edit ] Testing the cardiovascular response to prolonged head-up tilting, exercise, eating, and heat stress may help determine the best strategy for managing symptoms. [34] POTS has also been divided into several types (see § Causes), which may benefit from distinct treatments. [77] People with neuropathic POTS show a loss of sweating in the feet during sweat tests, as well as impaired norepinephrine release in the leg, [78] but not arm. [1] [77] [79] This is believed to reflect peripheral sympathetic denervation in the lower limbs. [78] [80] [1] People with hyperadrenergic POTS show a marked increase of blood pressure and norepinephrine levels when standing, and are more likely to have from prominent palpitations, anxiety, and tachycardia. [81] [82] [50] [77] Boris JR, Bernadzikowski T (December 2018). "Utilisation of medications to reduce symptoms in children with postural orthostatic tachycardia syndrome". Cardiology in the Young. 28 (12): 1386–1392. doi: 10.1017/S1047951118001373. PMID 30079848. S2CID 51922967.a b Kharraziha I, Axelsson J, Ricci F, Di Martino G, Persson M, Sutton R, etal. (August 2020). "Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural Orthostatic Tachycardia Syndrome". Journal of the American Heart Association. 9 (15): e015989. doi: 10.1161/JAHA.120.015989. PMC 7792263. PMID 32750291.

Sheldon RS, Grubb BP, Olshansky B, Shen WK, Calkins H, Brignole M, etal. (June 2015). "2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope". Heart Rhythm. 12 (6): e41–e63. doi: 10.1016/j.hrthm.2015.03.029. PMC 5267948. PMID 25980576. a b Blitshteyn S, Fedorowski A (12 December 2022). "The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: it's worth a shot". Nature Cardiovascular Research. 1 (12): 1119–1120. doi: 10.1038/s44161-022-00180-z. ISSN 2731-0590. S2CID 254617706.a b c d Vernino S, Stiles LE (December 2018). "Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding". Autonomic Neuroscience. Postural Orthostatic Tachycardia Syndrome (POTS). 215: 78–82. doi: 10.1016/j.autneu.2018.04.005. PMID 29909990. Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G (December 2006). "Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine". Clinical Autonomic Research. 16 (6): 390–395. doi: 10.1007/s10286-006-0373-0. PMID 17036177. S2CID 22288783. The two drugs had similar potencies; combination therapy was not significantly better than monotherapy. Fludrocortisone may be used to enhance sodium retention and blood volume, which may be beneficial not only by augmenting sympathetically mediated vasoconstriction, but also because a large subset of POTS patients appear to have low absolute blood volume. [87] However, fludrocortisone may cause hypokalemia. [88] Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Grubb BP (January 2012). "Use of methylphenidate in the treatment of patients suffering from refractory postural tachycardia syndrome". American Journal of Therapeutics. 19 (1): 2–6. doi: 10.1097/MJT.0b013e3181dd21d2. PMID 20460983. S2CID 11453764. More recently, autoantibodies against other targets have been identified in small cohorts of POTS patients. [61] Signs of innate immune system activation with elaboration of pro-inflammatory cytokines has also been reported in a cohort of POTS patients. [62] Secondary POTS [ edit ]

a b c Raj SR (April 2006). "The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management". Indian Pacing and Electrophysiology Journal. 6 (2): 84–99. PMC 1501099. PMID 16943900.Schondorf R, Low PA (January 1993). "Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia?". Neurology. 43 (1): 132–137. doi: 10.1212/WNL.43.1_Part_1.132. PMID 8423877. S2CID 43860206. Knight J (2018). "Effects of Bedrest: Introduction and the Cardiovascular System". Nursing Times. 114 (12): 54–57. Archived from the original on 2022-08-10 . Retrieved 2022-08-10– via EMAP.